ARCHIVES

FDA Approves Rituxan For CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999

In Brief: Lawsuit Could Delay Diet-Nutrition Cregs; Hugh Davis Replaces Mercado As CIB Chief

June 18, 1976

NCI Clarifies P01 Grant Application Dates

September 13, 1996

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

NCI Offers 200 Cell Lines to Scientist

May 6, 1983

FDA Approves Afinitor Tablets For Advanced Breast Cancer

August 31, 2012